Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
iSERA LifesciencesBOM:534920 20 Shareholder Yield % is -7.26% as of Mar. 2026. GuruFocus rates BOM:534920 with a GF Score™ of 20/100. The stock has 5 warning signs investors should review. Among 2,702 Software companies, iSERA Lifesciences ranks worse than 79.16% on this metric.
Shareholder Yield % is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. It is a measure of shareholder return.
As of today, iSERA Lifesciences's Shareholder Yield % was -7.26%.
Shareholder Yield % is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. The term was coined by William W. Priest of Epoch Investment Partners in a paper in 2005 entitled The Case for Shareholder Yield as a Dominant Driver of Future Equity Returns. William Priest indicated that "shareholder yield is a term that we came up with to reflect the various ways dividends can be paid to owners of a business in a publicly-traded company."
Dividend Yield % shows how much a company pays out in dividends each year relative to its stock price, which is most obvious form of shareholder return.
Buyback Yield % is the net repurchase of shares outstanding over the market capital of the company. Shares repurchases also increase shareholder value by returning the money back to shareholders.
Net Debt Paydown Yield % is the change in average of four quarters of company's total debt over a company's market cap. Assuming the total value of a company remains that same, shareholder value is increased as debt is reduced.
iSERA Lifesciences Shareholder Yield % Related Terms
iSERA Lifesciences Shareholder Yield % Historical Data
* Premium members only.
The historical data trend for iSERA Lifesciences's Shareholder Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:534920 vs IBM, ACN, FISV: Shareholder Yield % Comparison
For the Information Technology Services subindustry, iSERA Lifesciences's Shareholder Yield %, along with its competitors' market caps and Shareholder Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
iSERA Lifesciences Shareholder Yield % vs Software Industry
For the Software industry and Technology sector, iSERA Lifesciences's Shareholder Yield % distribution charts can be found below:
* The bar in red indicates where iSERA Lifesciences's Shareholder Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* All the data are calculated by TTM values. Note that if a companies is traded in several exchanges, then we calculate the company level data for Shareholder Yield % using the primary share class stock data. The calculation result in definition page is for demonstration purpose only, and it's showing the share class level data. Therefore, the numbers in the calculation may differ from elsewhere if the stock is not a primary share.
iSERA Lifesciences (BOM:534920) has a Shareholder Yield % of -7.26% as of Mar. 2026. Shareholder Yield is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. View historical data on iSERA Lifesciences and its competitors. According to the industry distribution chart, iSERA Lifesciences ranks #2139 out of 2702 companies in the Software industry, placing it in the top 79.2%.
Is iSERA Lifesciences' Shareholder Yield % too high?
iSERA Lifesciences' current Shareholder Yield % is -7.26%. Based on the distribution chart, iSERA Lifesciences ranks #2139 out of 2702 companies in the Software industry, which is in the bottom quartile relative to peers. Overall, iSERA Lifesciences has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does iSERA Lifesciences' Shareholder Yield % compare to IBM and ACN?
According to the Software industry distribution chart, iSERA Lifesciences ranks #2139 out of 2702 companies for Shareholder Yield %. This places iSERA Lifesciences in the lower half of its industry. The industry median Shareholder Yield % is 0.35. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Shareholder Yield % for a Software company?
The median Shareholder Yield % among Software companies is 0.35, based on 2,702 companies in the industry. Companies in the top quartile (top 25%) have a Shareholder Yield % significantly above this median, while those in the bottom quartile fall well below. However, Shareholder Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Shareholder Yield % mean?
A high Shareholder Yield % can signal that a stock is expensive relative to its fundamentals. Shareholder Yield is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. View historical data on iSERA Lifesciences and its competitors. For the Software industry, the median Shareholder Yield % is 0.35 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. iSERA Lifesciences's current Shareholder Yield % is -7.26%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is iSERA Lifesciences stock overvalued right now?
iSERA Lifesciences (BOM:534920) has a current Shareholder Yield % of -7.26%. The current Shareholder Yield % is -7.26%. iSERA Lifesciences' overall GF Score™ is 20/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Shareholder Yield % calculated?
Shareholder Yield % is calculated from a company's financial statements. For iSERA Lifesciences (BOM:534920), the current Shareholder Yield % is -7.26% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
iSERA Lifesciences Ltd, formally known as Covidh Technologies Ltd, is a technology services provider. The company provides IT and IT-enabled services. It derives revenue majorly from the sale of IT and IT-enabled services and Hardware.
20GF Score
Get the complete analysis for BOM:534920
Shareholder Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:534920 has been successfully added to your 
